- Home
- RGCO vs FDMT Comparison
RGCO vs FDMT Comparison
Compare RGCO & FDMT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RGCO
- FDMT
- Stock Information
- Founded
- RGCO 1912
- FDMT 2013
- Country
- RGCO United States
- FDMT United States
- Employees
- RGCO N/A
- FDMT N/A
- Industry
- RGCO Oil & Gas Production
- FDMT Biotechnology: Pharmaceutical Preparations
- Sector
- RGCO Utilities
- FDMT Health Care
- Exchange
- RGCO Nasdaq
- FDMT Nasdaq
- Market Cap
- RGCO 221.2M
- FDMT 192.2M
- IPO Year
- RGCO N/A
- FDMT 2020
- Fundamental
- Price
- RGCO $21.79
- FDMT $6.81
- Analyst Decision
- RGCO
- FDMT Buy
- Analyst Count
- RGCO 0
- FDMT 9
- Target Price
- RGCO N/A
- FDMT $30.63
- AVG Volume (30 Days)
- RGCO 15.6K
- FDMT 643.1K
- Earning Date
- RGCO 11-12-2025
- FDMT 11-12-2025
- Dividend Yield
- RGCO 3.81%
- FDMT N/A
- EPS Growth
- RGCO 5.90
- FDMT N/A
- EPS
- RGCO 1.32
- FDMT N/A
- Revenue
- RGCO $94,120,500.00
- FDMT $33,000.00
- Revenue This Year
- RGCO $14.48
- FDMT $8,572.97
- Revenue Next Year
- RGCO $2.11
- FDMT N/A
- P/E Ratio
- RGCO $16.45
- FDMT N/A
- Revenue Growth
- RGCO 12.04
- FDMT N/A
- 52 Week Low
- RGCO $19.06
- FDMT $2.24
- 52 Week High
- RGCO $24.20
- FDMT $17.41
- Technical
- Relative Strength Index (RSI)
- RGCO 48.02
- FDMT 56.27
- Support Level
- RGCO $21.54
- FDMT $6.09
- Resistance Level
- RGCO $22.48
- FDMT $7.21
- Average True Range (ATR)
- RGCO 0.59
- FDMT 0.44
- MACD
- RGCO -0.06
- FDMT -0.04
- Stochastic Oscillator
- RGCO 28.83
- FDMT 58.74
About RGCO RGC Resources Inc.
RGC Resources Inc is involved in the business of distribution and sale of natural gas to residential, commercial, and industrial customers within its service territory in Roanoke, Virginia, and its surrounding localities. The company also provides certain non-regulated services. The company relies on multiple interstate pipelines to transport natural gas. The company operates in three segments: Gas Utility, which is the key revenue generator; Investment in Affiliates this segment reflects the income generated through the activities of the Company's investment in MVP and Southgate projects and Parent & Other including the unregulated activities of the Company as well as certain corporate eliminations.
About FDMT 4D Molecular Therapeutics Inc.
4D Molecular Therapeutics Inc is a clinical-stage gene therapy company engaged in the development of product candidates using targeted and evolved AAV vectors. It has built a portfolio of gene therapy product candidates focused on three therapeutic areas: Ophthalmology (intravitreal vector) includes 4D-150, 4D-125, 4D-110, and 4D-175; Cardiology (intravenous vector) includes 4D-710, 4D-725, and Pulmonology (aerosol vector) 4D-310.